Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme

Takanori Kamiryo, Kenji Tada, Shoji Shiraishi, Naoki Shinojima, Hideo Nakamura, Masato Kochi, Jun Ichi Kuratsu, Hideyuki Saya, Yukitaka Ushio

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Object. One of the most frequent genetic abnormalities found in patients with glioblastoma multiforme (GBM) is homozygous deletion of the p16 tumor suppressor gene. The authors investigated whether this deletion is associated with prognosis in patients with GBM. Methods. In 46 adult patients with supratentorial GBM, homozygous deletion of the p16 gene in tumor DNA was examined using the multiplex polymerase chain reaction assay. The deletion was confirmed in 14 (30.4%) of 46 patients, eight (30.8%) of 26 men and six (30.0%) of 20 women. Cox proportional hazard regression analysis, adjusted for age at surgery, the Karnofsky Performance Scale score, extent of resection, and the MIB-1 labeling index, revealed that homozygous deletion of the p16 gene was significantly associated with overall survival and progression-free survival in men, but not in women. Conclusions. The results of this study suggest that p16 homozygous deletion is a significant unfavorable prognostic factor in male patients with GBM.

Original languageEnglish
Pages (from-to)815-822
Number of pages8
JournalJournal of Neurosurgery
Volume96
Issue number5
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

p16 Genes
Glioblastoma
Survival
Karnofsky Performance Status
Multiplex Polymerase Chain Reaction
Tumor Suppressor Genes
Disease-Free Survival
Regression Analysis
DNA
Neoplasms

Keywords

  • Glioblastoma multiforme
  • Homozygous deletion
  • p16 gene
  • Prognosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Kamiryo, T., Tada, K., Shiraishi, S., Shinojima, N., Nakamura, H., Kochi, M., ... Ushio, Y. (2002). Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. Journal of Neurosurgery, 96(5), 815-822.

Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. / Kamiryo, Takanori; Tada, Kenji; Shiraishi, Shoji; Shinojima, Naoki; Nakamura, Hideo; Kochi, Masato; Kuratsu, Jun Ichi; Saya, Hideyuki; Ushio, Yukitaka.

In: Journal of Neurosurgery, Vol. 96, No. 5, 2002, p. 815-822.

Research output: Contribution to journalArticle

Kamiryo, T, Tada, K, Shiraishi, S, Shinojima, N, Nakamura, H, Kochi, M, Kuratsu, JI, Saya, H & Ushio, Y 2002, 'Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme', Journal of Neurosurgery, vol. 96, no. 5, pp. 815-822.
Kamiryo T, Tada K, Shiraishi S, Shinojima N, Nakamura H, Kochi M et al. Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. Journal of Neurosurgery. 2002;96(5):815-822.
Kamiryo, Takanori ; Tada, Kenji ; Shiraishi, Shoji ; Shinojima, Naoki ; Nakamura, Hideo ; Kochi, Masato ; Kuratsu, Jun Ichi ; Saya, Hideyuki ; Ushio, Yukitaka. / Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. In: Journal of Neurosurgery. 2002 ; Vol. 96, No. 5. pp. 815-822.
@article{85219a42f72c4bbda22bd2445ae83f77,
title = "Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme",
abstract = "Object. One of the most frequent genetic abnormalities found in patients with glioblastoma multiforme (GBM) is homozygous deletion of the p16 tumor suppressor gene. The authors investigated whether this deletion is associated with prognosis in patients with GBM. Methods. In 46 adult patients with supratentorial GBM, homozygous deletion of the p16 gene in tumor DNA was examined using the multiplex polymerase chain reaction assay. The deletion was confirmed in 14 (30.4{\%}) of 46 patients, eight (30.8{\%}) of 26 men and six (30.0{\%}) of 20 women. Cox proportional hazard regression analysis, adjusted for age at surgery, the Karnofsky Performance Scale score, extent of resection, and the MIB-1 labeling index, revealed that homozygous deletion of the p16 gene was significantly associated with overall survival and progression-free survival in men, but not in women. Conclusions. The results of this study suggest that p16 homozygous deletion is a significant unfavorable prognostic factor in male patients with GBM.",
keywords = "Glioblastoma multiforme, Homozygous deletion, p16 gene, Prognosis",
author = "Takanori Kamiryo and Kenji Tada and Shoji Shiraishi and Naoki Shinojima and Hideo Nakamura and Masato Kochi and Kuratsu, {Jun Ichi} and Hideyuki Saya and Yukitaka Ushio",
year = "2002",
language = "English",
volume = "96",
pages = "815--822",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

TY - JOUR

T1 - Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme

AU - Kamiryo, Takanori

AU - Tada, Kenji

AU - Shiraishi, Shoji

AU - Shinojima, Naoki

AU - Nakamura, Hideo

AU - Kochi, Masato

AU - Kuratsu, Jun Ichi

AU - Saya, Hideyuki

AU - Ushio, Yukitaka

PY - 2002

Y1 - 2002

N2 - Object. One of the most frequent genetic abnormalities found in patients with glioblastoma multiforme (GBM) is homozygous deletion of the p16 tumor suppressor gene. The authors investigated whether this deletion is associated with prognosis in patients with GBM. Methods. In 46 adult patients with supratentorial GBM, homozygous deletion of the p16 gene in tumor DNA was examined using the multiplex polymerase chain reaction assay. The deletion was confirmed in 14 (30.4%) of 46 patients, eight (30.8%) of 26 men and six (30.0%) of 20 women. Cox proportional hazard regression analysis, adjusted for age at surgery, the Karnofsky Performance Scale score, extent of resection, and the MIB-1 labeling index, revealed that homozygous deletion of the p16 gene was significantly associated with overall survival and progression-free survival in men, but not in women. Conclusions. The results of this study suggest that p16 homozygous deletion is a significant unfavorable prognostic factor in male patients with GBM.

AB - Object. One of the most frequent genetic abnormalities found in patients with glioblastoma multiforme (GBM) is homozygous deletion of the p16 tumor suppressor gene. The authors investigated whether this deletion is associated with prognosis in patients with GBM. Methods. In 46 adult patients with supratentorial GBM, homozygous deletion of the p16 gene in tumor DNA was examined using the multiplex polymerase chain reaction assay. The deletion was confirmed in 14 (30.4%) of 46 patients, eight (30.8%) of 26 men and six (30.0%) of 20 women. Cox proportional hazard regression analysis, adjusted for age at surgery, the Karnofsky Performance Scale score, extent of resection, and the MIB-1 labeling index, revealed that homozygous deletion of the p16 gene was significantly associated with overall survival and progression-free survival in men, but not in women. Conclusions. The results of this study suggest that p16 homozygous deletion is a significant unfavorable prognostic factor in male patients with GBM.

KW - Glioblastoma multiforme

KW - Homozygous deletion

KW - p16 gene

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0036239616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036239616&partnerID=8YFLogxK

M3 - Article

C2 - 12005388

AN - SCOPUS:0036239616

VL - 96

SP - 815

EP - 822

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 5

ER -